Eli Lilly on Wednesday disclosed the first human trial results to be made public for an antibody drug meant to either prevent or treat COVID-19, showing some signs of a potential benefit.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,